Stock Analysis on Net
Stock Analysis on Net

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

Analysis of Inventory

Microsoft Excel

Inventory Disclosure

Regeneron Pharmaceuticals Inc., balance sheet: inventory

US$ in thousands

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Raw materials 789,300 818,400 721,900 459,400 216,300
Work-in-process 1,121,800 963,100 707,200 904,600 727,700
Finished goods 147,300 98,600 73,700 121,700 70,600
Deferred costs 522,100 521,800 448,500 430,900 400,900
Inventories 2,580,500 2,401,900 1,951,300 1,916,600 1,415,500

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Item Description The company
Inventories Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Regeneron Pharmaceuticals Inc. inventories increased from 2021 to 2022 and from 2022 to 2023.